Characterization of Lysophospholipase D Activity in Mammalian Cell Membranes

Pravita Balijepalli · 2024-03-16

Lysophosphatidic acid (LPA) is a lipid mediator that binds to G-protein-coupled receptors, eliciting a wide variety of responses in mammalian cells. Lyso-phospholipids generated via phospholipase A2 (PLA2) can be converted to LPA by a lysophospholipase D (lyso-PLD). Secreted lyso-PLDs have been studied in more detail than membrane-localized lyso-PLDs. This study utilized in vitro enzyme assays with fluorescent substrates to examine LPA generation in membranes from multiple mammalian cell lines (PC12, rat pheochromocytoma; A7r5, rat vascular smooth muscle; Rat-1, rat fibroblast; PC-3, human prostate carcinoma; and SKOV-3 and OVCAR-3, human ovarian carcinoma). The results show that membranes contain a lyso-PLD activity that generates LPA from a fluorescent alkyl-lyso-phosphatidylcholine, as well as from naturally occurring acyl-linked lysophospholipids. Membrane lyso-PLD and PLD activities were distinguished by multiple criteria, including lack of effect of PLD2 over-expression on lyso-PLD activity and differential sensitivities to vanadate (PLD inhibitor) and iodate (lyso-PLD inhibitor). Based on several lines of evidence, including siRNA knockdown, membrane lyso-PLD is distinct from autotaxin, a secreted lyso-PLD. PC-3 cells express GDE4 and GDE7, recently described lyso-PLDs that localize to membranes. These findings demonstrate that membrane-associated lyso-D activity, expressed by multiple mammalian cell lines, can contribute to LPA production.

Journal
Cells
Funding
Training To Improve Cardiovascular TherapiesTowards the Discovery of HERG PAS Domain LigandsNIH HHS Grant CA58640National Institutes of Health Grant CA58640Towards the Discovery of HERG PAS Domain LigandsNational Institutes of Health Grant DAMD17-98-8524National Institutes of Health Grant DAMD17-01-1-0730U.S. Department of Defense Grant CA58640U.S. Department of Defense Grant HL07260U.S. Department of Defense Grant DAMD17-98-8524U.S. Department of Defense Grant DAMD17-01-1-0730UNCF/Merck Science Research Dissertation Fellowship Grant CA58640UNCF/Merck Science Research Dissertation Fellowship Grant HL07260UNCF/Merck Science Research Dissertation Fellowship Grant DAMD17-98-8524UNCF/Merck Science Research Dissertation Fellowship Grant DAMD17-01-1-0730the University Research Committee of the Medical University of South Carolina Grant CA58640the University Research Committee of the Medical University of South Carolina Grant HL07260the University Research Committee of the Medical University of South Carolina Grant DAMD17-98-8524the University Research Committee of the Medical University of South Carolina Grant DAMD17-01-1-0730the College of Pharmacy and Pharmaceutical Sciences at Washington State University Grant CA58640the College of Pharmacy and Pharmaceutical Sciences at Washington State University Grant HL07260the College of Pharmacy and Pharmaceutical Sciences at Washington State University Grant DAMD17-98-8524the College of Pharmacy and Pharmaceutical Sciences at Washington State University Grant DAMD17-01-1-0730

NHLBI NIH HHS

T32 HL007260